Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INT-787, a Novel Farnesoid X Receptor Agonist, in Healthy Volunteers: A Phase 1 Trial. - Capozza T; Burkey J; Van De Wetering J; Kerb R; Callahan J; Kryzhanovskaya L; Erickson M (Clinical and translational science, 2025)